SOUTH BANK SURGERY — All Prescriptions & Medications — Page 9
Practice Code: B86035 | LEEDS, LS10 2PT
Showing results 401-450 of 631
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Desmopressin acetate | 34 | 1,830 | £1.1K | -34.8% ▼ |
| Mefenamic acid | 34 | 1,917 | £381 | -24.7% ▼ |
| 34 | 638 | £111 | +148.8% ▲ | |
| 34 | 778 | £203 | +185.2% ▲ | |
| 34 | 2,352 | £5.8K | -14.8% ▼ | |
| Naftidrofuryl oxalate | 33 | 4,956 | £583 | +1.3% vs avg |
| Ciclosporin | 33 | 1,588 | £1.7K | +97.7% ▲ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 33 | 84.0K | £1.9K | +166.1% ▲ |
| Menthol | 33 | 13.7K | £496 | +17.2% ▲ |
| Aciclovir | 33 | 134 | £123 | +167.7% ▲ |
| 33 | 131 | £294 | +36.2% ▲ | |
| Promazine hydrochloride | 32 | 1,344 | £1.0K | -39.4% ▼ |
| Other compound vitamin/mineral formulation preparations | 32 | 1,148 | £141 | -0.2% vs avg |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 32 | 84.0K | £882 | +70.9% ▲ |
| Powder amino acid formula (0913107) | 32 | 70.4K | £4.5K | -3.1% ▼ |
| 32 | 4,000 | £115 | +148.0% ▲ | |
| 32 | 1,740 | £7.5K | +43.4% ▲ | |
| Mebendazole | 31 | 600 | £41 | +170.8% ▲ |
| Hepatitis A | 31 | 31 | £635 | -59.2% ▼ |
| 31 | 1,637 | £116 | -37.9% ▼ | |
| Moxonidine | 30 | 2,240 | £374 | -46.1% ▼ |
| Adrenaline | 30 | 58 | £3.5K | -52.4% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 30 | 1,015 | £58 | -25.3% ▼ |
| Levonorgestrel | 30 | 30 | £2.6K | -20.5% ▼ |
| Sodium feredetate | 30 | 14.7K | £416 | +4.8% ▲ |
| Dipyridamole | 29 | 2,640 | £550 | +13.0% ▲ |
| Citalopram hydrochloride | 29 | 525 | £355 | +80.7% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 29 | 3,720 | £58 | +26.5% ▲ |
| Meloxicam | 29 | 914 | £27 | -56.2% ▼ |
| Mupirocin | 29 | 102 | £137 | +147.0% ▲ |
| 29 | 420 | £1.4K | +4.2% ▲ | |
| 29 | 92 | £686 | +4.2% ▲ | |
| Fluvastatin sodium | 28 | 1,848 | £436 | +21.1% ▲ |
| Tibolone | 28 | 1,540 | £140 | -8.5% ▼ |
| 28 | 445 | £896 | +78.4% ▲ | |
| 28 | 434 | £361 | +8.1% ▲ | |
| 28 | 990 | £4.0K | +141.1% ▲ | |
| Formoterol/glycopyrronium/budesonide | 27 | 27 | £1.1K | -55.2% ▼ |
| Guanfacine | 27 | 924 | £2.1K | +5.1% ▲ |
| Erythromycin ethylsuccinate | 27 | 2,728 | £239 | +15.6% ▲ |
| Exemestane | 27 | 1,170 | £1.1K | -16.9% ▼ |
| Metformin hydrochloride/sitagliptin | 26 | 1,456 | £255 | -30.5% ▼ |
| Betamethasone sodium phosphate | 26 | 2,530 | £332 | +111.5% ▲ |
| Triamcinolone acetonide | 26 | 29 | £40 | -65.2% ▼ |
| Diethylamine salicylate | 26 | 2,600 | £81 | -3.7% ▼ |
| Other sunscreening preparations | 26 | 6,500 | £475 | +231.7% ▲ |
| 26 | 715 | £2.4K | -33.9% ▼ | |
| Nadolol | 25 | 588 | £877 | +147.2% ▲ |
| Indacaterol/glycopyrronium | 25 | 750 | £772 | -44.6% ▼ |
| Clobazam | 25 | 1,632 | £420 | -62.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.